# Achieve Life Sciences, Inc.: Form 8-K, filed Jul 6, 2026

- Company: [Achieve Life Sciences, Inc.](/companies/achv.md) (CIK 949858)
- Form: 8-K
- Filed: 2026-07-06
- Accepted by EDGAR: Jul 6, 2026, 20:06 ET
- Period: 2026-07-02
- Accession: 0001193125-26-296174
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/achv-20260702.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/achv-20260702.htm

Filed Jul 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-296174. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.